Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Strides Pharma Science LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:532531NSE Symbol: STARP/E(TTM):91.25
ISIN Demat:INE939A01011Div & Yield %:0.17EPS(TTM):9.53
Book Value(Rs):376.844232Market Cap ( Cr.):7991.6Face Value(Rs):10
    Change Company 
Date Headline
16-May-24 Strides Pharma Science Ltd - Strides Pharma Science Limited - Analysts/Institutional Investor Meet/Con. Call Updates
16-May-24 Strides Pharma Science Ltd - Strides Pharma Science Limited - Analysts/Institutional Investor Meet/Con. Call Updates
16-May-24 Strides Pharma Science Ltd - Strides Pharma Science Limited - Analysts/Institutional Investor Meet/Con. Call Updates
14-May-24 Strides Pharma Science to convene board meeting
14-May-24 Strides Pharma Science Ltd - Strides Pharma Science Limited - Board Meeting
10-May-24 Strides Pharma Global receives USFDA approval for Sevelamer Carbonate Tablets, 800 mg
10-May-24 Strides Pharma rises afte receiving US FDA nod for hyperphosphatemia treatment drug
10-May-24 Strides Pharma Science Ltd - Strides Pharma Science Limited - Press Release
10-May-24 Strides Pharma Science Ltd - Strides Pharma Science Limited - Press Release
07-May-24 Strides Pharma Science Ltd - Strides Pharma Science Limited - Other General Purpose
<< < 1 2 3 4   > >>